Free shipping on international order of $150+
Fast & International Shipping
International click & collect

Best Healthcare Stocks of April 2023

dividend stocks

It’s why many analysts are predicting volatility to continue, for at least the first half of 2023. You could, but then you risk missing out on the best days when the market starts to turn. It’s difficult to predict exactly how the stock market will react to a government shutdown, as it will depend on the specific circumstances and length of the shutdown. A few days isn’t likely to cause many concerns, but a longer period of time could add to the uncertainty surrounding equities.

The how do squatter’s rights work of the organized sector is almost 25% in this segment (15% in labs and 10% in radiology). Healthcare investors hoping for more gains just might have to be patient. Shares of Merck , with a $281 billion market cap, are flat so far in 2023 following a decline on Monday.

Medical Device Healthcare Stocks

Indiana-based pharmaceutical firm Eli Lilly employs more than 34,000 employees across 18 countries and sells its products in 120 different countries. The company was founded in 1876 by Colonel Eli Lilly, who was a veteran of the Civil War. One of the first products it developed was quinine, a medication used to treat malaria. However, the company’s generous dividend yield is one of the main reasons people consider investing in this stock. There are plenty of fantastic healthcare stocks in Canada and a lot of variety to choose from. CFD accounts provided by IG Markets Ltd, spread betting provided by IG Index Ltd and share dealing and stocks and shares ISA accounts provided by IG Trading and Investments Ltd.

It is considered a world leader in all of its core businesses, but is most famous for developing the first HIV blood screening test in 1985. Abbott Labs later spun off its pharmaceutical arm AbbVie, which is also one of the largest global healthcare stocks. For example, biopharmaceutical companies, medical device makers, and healthcare providers can be sued if patients think the companies’ products and services have caused them harm. ResMed, Inc. engages in providing digital health and cloud-connected medical devices.


The company’s drug Mounjaro is a direct competitor to Wegovy and Ozempic, although not yet approved for weight loss. UnitedHealth’s consistent revenue growth and strong returns on equity continue to make it a strong choice in 2023. It closed out the fiscal year 2022 with its fourth consecutive quarter of double-digit growth, at 12%.

#39 – Alexion Pharmaceuticals

If it isn’t, make sure you learn how it plans to achieve profitability and how quickly it expects to do so. The two are working together to develop gene-editing therapy exa-cel to treat beta-thalassemia and sickle cell disease, two rare blood disorders. To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.


Biotech firms include small startup companies and larger, more established drug makers such as Amgen and Biogen. BioNTech has become a well-known biotech name as Pfizer’s partner in developing the COVID-19 vaccine. At the same time, because of the lower prices, generic drug makers experience thinner profit margins. In addition, many manufacturers have been under fire for faulty formulas and quality standards. Founded in 1856, Smith & Nephew is one of the oldest medical device manufacturers in the world.

S&P Sectors – health care

Thanks to the nature of its business, the company has significant expenses, and the largest of them is likely the staffing. It’s already the largest network of dental practices in the country, with over 445 locations and over 7,100 team members . The network as a whole caters to about four million patients a year. Please note, we may receive affiliate compensation for some of the links below at no additional cost to you. This does not affect the objectivity of the products we recommend or the ratings assigned to them. You can read my full affiliate disclosure in my terms and conditions.


Aging demographic trends across the world, combined with advances in technology, should open up tremendous opportunities for healthcare stocks — and provide healthy returns for patient investors. Health care has been known as one of the best defensive sectors because they have typically been unchanged due to economic demands. The healthcare sector will continue to pour billions into long-term growth pipelines in high-growth streams like infectious diseases, cancer, virology and neurological diseases.

Its pharma products include products in the category of anesthetics, pain management, ophthalmology, and injectables. Restoration of elective patient treatment post covid to boost this specialty segment business. But, no matter what we are never going to compromise with our health and hence the healthcare industry is forever going to be in the spotlight.

They pay the bills, so, the better the underwriting, the lower the medical costs incurred by the insurance company will be. The dividend yield tells you how large a stock’s annual dividend payments are as a percentage of the current share price. Consider the stock’s payout ratio, which measures dividends as a percentage of earnings and indicates how much of the company’s cash is being used to cover the dividend.

Given its access to vast resources, the group develops new treatments for a wide range of diseases. The list includes cancer, cardiovascular, renal respiratory diseases, and immunology and other rarer conditions. Others are still focusing on developing and getting approval for other drugs to help treat victims of the coronavirus. Still, other companies have developed and continue to develop testing methods for the coronavirus. Because several companies in the market have been developing and providing healthcare services in new ways, some traders consider it a good time to invest in the right healthcare stocks.

Timely and effective diagnostic tests have helped us beat Covid with limited damage. Healthcare sector becomes very important for any nation in this pandemic. Mac Crawford is a veteran healthcare CEO and M&A expert, known as one of the most successful turnarounds and restructuring executives in the industry.

Love Dividends? These 3 Stocks Are Smart Buys Right Now – The Motley Fool

Love Dividends? These 3 Stocks Are Smart Buys Right Now.

Posted: Sun, 09 Apr 2023 09:27:00 GMT [source]

Humana is second in Medicare Advantage plans, with an 18% market share as of 2022, behind only UnitedHealth, which has 28% share, Utterback said. Neither the author nor editor held positions in the aforementioned investments at the time of publication. Medical device companies, such as Medtronic, design and manufacture machines that are used to treat specific health issues, such as pacemakers and ventilators. Investing in Health Insurance Stocks Health insurance is a necessity today, which means it’s a great addition to your portfolio.

Healthcare real estate investment funds, therefore, prove to be a viable option for investment. However, remember to research the credit ratings of the REITs before investing in one. With Admirals, you can buy the top health care stocks and medical ETFs with a competitive commission of just 0.02 USD per share and with a low minimum commission of just $1.0 on US-listed instruments. Medical insurance firms are also an important player in the healthcare services sector.

So, let’s explore the risks and rewards of investing in healthcare shares a bit further. These stocks are having trouble seeing more gains for the moment because many of them are more expensive then investors would apparently like them to be. The healthcare fund’s aggregate dividend yield for 2023 is about 1.7%, well below the yield of more than 3% on safe 10-year Treasury debt. Karuna Therapeutics, Inc operates as a clinical-stage biopharmaceutical company. Engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.

  • The deal is significant at US$12.5bn in size, and exhausts all balance sheet latency in one fell swoop.
  • Consequently any person acting on it does so entirely at their own risk.
  • It’s a multinational pharmaceutical and medical devices manufacturer based in the US, which consists of 250 companies – collectively called the ‘Johnson & Johnson family of companies’.
  • Despite these risks, the overall outlook for healthcare stocks appears very good over the long term.

Not just that the hospital has also emerged as Asia’s foremost integrated healthcare services provider as it has a solid presence in the healthcare sector. This includes hospitals, pharmacies, primary care & diagnostic clinics and several retail health models. In the wake of the pandemic, the healthcare sector will likely get further public and private investment, helping drive innovation and profits. Moreover, an aging baby boomer population continues to underpin the space, creating additional demand for medical products and services. According to the Centers for Medicare and Medicaid Services, U.S. national healthcare expenditure is expected to reach $6.2 trillion by 2028, highlighting the sector’s size. When you invest in healthcare stocks, you’ll be buying shares in a company or a healthcare exchange traded fund outright.

It also mentions the ratios and pros and cons of investing in the company. As defensive stocks, healthcare companies provide steady returns in any market. Because people will always need healthcare, the healthcare sector provides very steady, consistent returns that are uncorrelated with the overall direction of the stock market. If those numbers have you ready to load up on healthcare stocks, you’ve got thousands of options. To help you cut through the noise in your research, these are the 10 top healthcare stocks by market capitalization.

Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA. Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases.

Leave a Reply

Your email address will not be published. Required fields are marked *

Shopping Cart (0)


× How can I help you?